Anti-Keap1 antibody [1B4]

• Supplier: Abcam
• Catalog: ab119403
• Prices: $385.00
• Sizes: 100 µl
• Host: Mouse
• Clonality: Monoclonal
• Isotype: IgG1
• Clone: 1B4
• Applications: WB IHC-P FC
• Species Reactivities: Mouse, Human
• Antigen: Recombinant full length Human Keap1 produced in HEK293T cells (NP_987096)
• Description: Mouse Monoclonal
• Gene: KEAP1
• Conjugate: Unconjugated

Product images

All lanes : Anti-Keap1 antibody [1B4] (ab119403) at 1/500 dilutionLane 1 : HEK293T cell lysate transfected with pCMV6-ENTRY control cDNALane 2 : HEK293T cell lysate transfected with pCMV6-ENTRY Keap1 cDNALysates/proteins at 5 µg per lane.developed using the ECL technique

All lanes : Anti-Keap1 antibody [1B4] (ab119403) at 1/500 dilutionLane 1 : HepG2 cell extractLane 2 : HeLa cell extractLane 3 : SVT2 cell extractLane 4 : A549 cell extractLane 5 : COS7 cell extractLane 6 : Jurkat cell extractLane 7 : MDCK cell extractLane 8 : PC12 cell extractLane 9 : MCF7 cell extractLysates/proteins at 35 µg per lane.developed using the ECL technique

ab119403 at 1/150 dilution staining Keap1 in paraffin-embedded Human endometrium tissue by Immunohistochemistry.

ab119403 at 1/150 dilution staining Keap1 in paraffin-embedded Human endometrium adenocarcinoma tissue by Immunohistochemistry.

ab119403 at 1/150 dilution staining Keap1 in paraffin-embedded Human bladder carcinoma tissue by Immunohistochemistry.

ab119403 at 1/100 dilution staining Keap1 in HEK293T cells transfected with either pCMV6-ENTRY Keap1 overexpress plasmid (Red) or empty vector control plasmid (Blue) and then analysed by Flow Cytometry.

ab119403 at 1/100 dilution staining Keap1 in HeLa cells by Flow cytometry (Red) compared to a nonspecific negative control antibody (Blue).

ab119403 at 1/100 dilution staining Keap1 in Jurkat cells by Flow cytometry (Red) compared to a nonspecific negative control antibody (Blue).

Product References

Nrf2 is commonly activated in papillary thyroid carcinoma, and it controls - Nrf2 is commonly activated in papillary thyroid carcinoma, and it controls

Ziros PG, Manolakou SD, Habeos IG, Lilis I, Chartoumpekis DV, Koika V, Soares P, Kyriazopoulou VE, Scopa CD, Papachristou DJ, Sykiotis GP. J Clin Endocrinol Metab. 2013 Aug;98(8):E1422-7.